Heart disease has been the leading cause of death in the U.S. for 100 years, according to the American Heart Association’s 2024 Heart Disease and Stroke Statistics report. For decades, beta-blockers ...
It seems like every few weeks, there’s a new “miracle fix” for anxiety trending on social media. The latest is a decades-old heart medication that more and more people are saying helps them stay calm ...
If you experience frequent migraine attacks, you may already know that prevention is the best medicine. One of the first medications your doctor is likely to prescribe for preventing your next attack ...
Not sure about you, but nervous energy comes at me like a bat out of hell. And, of course, it’s always at the literal worst moments. Big job interview? My heart races like it’s at the Olympics.
An unlikely byproduct of the Oscars red-carpet coverage last Sunday? The mention of beta blockers by actor Rachel Sennott, who told a host that her pre-event routine is to “take that beta blocker, ...
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." While lorazepam has been the talk of the town thanks to The White Lotus, there’s another med competing ...
Without question, there is a fair deal of negative stigma surrounding traditional psychopharmaceutical treatments for problems such as anxiety, depression, and panic. While these medications of ...
Beta-blockers are a type of medication used after heart attacks. A recent study suggests that using beta-blockers does not improve certain outcomes after heart attacks where the left ventricular ...
Madrid, Spain – 30 August 2025: Beta-blocker therapy significantly reduced a composite endpoint of all-cause mortality and major adverse cardiovascular events compared with no beta-blocker therapy in ...
The findings confirm the results of the CNIC-led REBOOT clinical trial and consolidate a paradigm shift in infarction treatment. A major analysis led by the Centro Nacional de Investigaciones ...
WEDNESDAY, Sept. 3, 2025 (HealthDay News) — A drug commonly prescribed to heart attack survivors may not benefit many of them, a new clinical trial has found. Beta-blockers do not appear to reduce the ...
PARIS, France—Patients with myocardial infarction and preserved LVEF who stop their beta-blocker have significant rises in heart rate and blood pressure that appear to increase the likelihood of ...